These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys. Lee B; Shi L; Kassel DB; Asakawa T; Takeuchi K; Christopher RJ Eur J Pharmacol; 2008 Jul; 589(1-3):306-14. PubMed ID: 18538760 [TBL] [Abstract][Full Text] [Related]
8. Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279): a very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes. Madar DJ; Kopecka H; Pireh D; Yong H; Pei Z; Li X; Wiedeman PE; Djuric SW; Von Geldern TW; Fickes MG; Bhagavatula L; McDermott T; Wittenberger S; Richards SJ; Longenecker KL; Stewart KD; Lubben TH; Ballaron SJ; Stashko MA; Long MA; Wells H; Zinker BA; Mika AK; Beno DW; Kempf-Grote AJ; Polakowski J; Segreti J; Reinhart GA; Fryer RM; Sham HL; Trevillyan JM J Med Chem; 2006 Oct; 49(21):6416-20. PubMed ID: 17034148 [TBL] [Abstract][Full Text] [Related]
9. 1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors. Lübbers T; Böhringer M; Gobbi L; Hennig M; Hunziker D; Kuhn B; Löffler B; Mattei P; Narquizian R; Peters JU; Ruff Y; Wessel HP; Wyss P Bioorg Med Chem Lett; 2007 Jun; 17(11):2966-70. PubMed ID: 17418568 [TBL] [Abstract][Full Text] [Related]
10. Discovery and structure-activity relationships of piperidinone- and piperidine-constrained phenethylamines as novel, potent, and selective dipeptidyl peptidase IV inhibitors. Pei Z; Li X; von Geldern TW; Longenecker K; Pireh D; Stewart KD; Backes BJ; Lai C; Lubben TH; Ballaron SJ; Beno DW; Kempf-Grote AJ; Sham HL; Trevillyan JM J Med Chem; 2007 Apr; 50(8):1983-7. PubMed ID: 17367123 [TBL] [Abstract][Full Text] [Related]
11. 4-aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV. Duffy JL; Kirk BA; Wang L; Eiermann GJ; He H; Leiting B; Lyons KA; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE Bioorg Med Chem Lett; 2007 May; 17(10):2879-85. PubMed ID: 17350841 [TBL] [Abstract][Full Text] [Related]
13. Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes. Deacon CF Curr Opin Investig Drugs; 2008 Apr; 9(4):402-13. PubMed ID: 18393107 [TBL] [Abstract][Full Text] [Related]
14. Substituted piperazines as novel dipeptidyl peptidase IV inhibitors. Brockunier LL; He J; Colwell LF; Habulihaz B; He H; Leiting B; Lyons KA; Marsilio F; Patel RA; Teffera Y; Wu JK; Thornberry NA; Weber AE; Parmee ER Bioorg Med Chem Lett; 2004 Sep; 14(18):4763-6. PubMed ID: 15324904 [TBL] [Abstract][Full Text] [Related]
15. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. Villhauer EB; Brinkman JA; Naderi GB; Burkey BF; Dunning BE; Prasad K; Mangold BL; Russell ME; Hughes TE J Med Chem; 2003 Jun; 46(13):2774-89. PubMed ID: 12801240 [TBL] [Abstract][Full Text] [Related]
16. Gamma-amino-substituted analogues of 1-[(S)-2,4-diaminobutanoyl]piperidine as highly potent and selective dipeptidyl peptidase II inhibitors. Senten K; Van Der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K J Med Chem; 2004 May; 47(11):2906-16. PubMed ID: 15139769 [TBL] [Abstract][Full Text] [Related]